Edupreneur Editorial Team23 April 2025
The U.S. Food and Drug Administration (FDA) has asked Novavax to commit to providing additional clinical data on its COVID-19 vaccine before granting full approval. This request follows the agency’s missed April 1 deadline to make a decision on traditional approval for the shot. What’s the Issue? Although Novavax’s vaccine has been available under emergency […]
